Late-life semaglutide extends lifespan in mice and mimics caloric restriction
UC Berkeley researchers administered semaglutide to mice at the equivalent of late human middle age and observed lifespan extension and molecular signatures matching caloric restriction across mTOR, AMPK, and insulin signalling pathways -- without any reduction in food intake.